Fenoldopam mesylate (Corlopam) is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist.

Fenoldopam is used as an antihypertensive agent.

It was approved by the Food and Drug Administration (FDA) in September 1997.